The outbreak of bluetongue virus (BTV) serotype 8 (BTV-8) during 2006-2009 in Europe was the most costly epidemic of the virus in recorded history. In 2015, a BTV-8 strain re-emerged in France which has continued to circulate since then. To examine anecdotal reports of reduced pathogenicity and transmission efficiency, we investigated the infection kinetics of a 2007 UK BTV-8 strain alongside the re-emerging BTV-8 strain isolated from France in 2017. Two groups of eight BTV-naïve British mule sheep were inoculated with 5.75 log 10 TCID 50 /ml of either BTV-8 strain.
| INTRODUCTION
Bluetongue (BT) is an infectious haemorrhagic disease of ruminants caused by the bluetongue virus (BTV) which is transmitted via Culicoides biting midges (Carpenter, Groschup, Garros, Felippe-Bauer, & Purse, 2013) . BTV is the type species of the genus Orbivirus within the family Reoviridae and is a serologically and genetically diverse virus. The BTV genome is comprised of 10 double-stranded RNA segments encoding several structural and non-structural proteins.
BTV segment-2 encodes the most variable BTV protein (VP2) which contains the majority of epitopes that interact with neutralising antibodies (Maclachlan, Henderson, Schwartz-Cornil, & Zientara, 2014) .
Since 1998, a number of BTV serotypes have caused both sporadic and widespread incursions into the EU (Belbis et al., 2017) .
In August 2006, a BTV serotype 8 (BTV-8) strain of sub-Saharan origin (Maan et al., 2008) In August 2015, BTV-8 re-emerged in France and subsequently spread throughout the entire country . How BTV-8 persisted in areas that were thought to have been free of virus transmission remains unknown, although it has been recently proposed that low-level circulation of BTV-8 occurred in France prior to the detection in 2015 (Courtejoie et al., 2018) . Importantly however, anecdotal observation suggested that changes had occurred in the epidemiology of the re-emerging strain. Whereas the [2007] [2008] [2009] BTV-8 strain caused widespread clinical signs in cattle and sheep (Elbers, Spek, & Rijn, 2009; Zanella et al., 2013) , the re-emerging BTV-8 strain has thus far only caused mild clinical illness . In addition, the rate of spread of the virus in France appeared slower than the original BTV-8 strain. At the time of the BTV-8 re-emergence in 2015, it had been estimated that the ruminant herd immunity in France was 18% .
Genetically, the re-emerging BTV-8 strain (GenBank accession numbers: KP56990-KP56999) differs from a 2007 UK BTV-8 strain (accession numbers: KP820957, KP821077, KP821199, KP821319, KP821439, KP7821559, KP821681, KP821801, KP821921 and KP822042) in just 11 amino acids occurring in segments 1 (3), 2 (1), 3
(1), 4 (1), 8 (1), 9 (3) and 10 (1). The high degree of amino acid similarity between the 2007 and 2015 strains underpins the hypothesis that this is not a new introduction of BTV-8 .
In this study we directly compare the infection of sheep with the original and re-emerging European BTV-8 strains by assessing viraemia, clinical signs, antibody production and transmission to Culicoides biting midges. By using British mule sheep, representative of the UK flock from a region not originally exposed to BTV-8 infection, the aim is to understand if the changes in epidemiology and pathogenicity observed in France will also occur in regions beyond those affected by outbreaks from 2006 to 2009. The findings from this study will inform response in both the UK and other countries previously unaffected by BTV-8 and allow for evidence-based surveillance and control measures to be implemented. Both the UKG2007 and FRA2017 strains were re-passaged once on KC cells. Strains can be accessed via the European Virus Archive (https://www.european-virus-archive.com/evag-portal).
| MATERIALS AND METHODS

| Ethical statement for animal studies
| Preparation of inocula
Following harvest, viral inocula were titrated on KC cells using a 96-well titration assay in combination with immunofluorescence microscopy.
Briefly, 10-fold serial dilutions of the virus were added to KC cells immediately following addition of the cells to 96 well tissue culture plates. After 5 days incubation at 26°C, the cells were fixed using 4% paraformaldehyde for 45 min and following multiple washes with PBS were permeabilized with 0.2% Triton X-100 for 20 min following. Viral proteins were labelled using an anti-BTV polyclonal guinea-pig sera (ORAB279) and anti-guinea-pig-Alexa488 and immunofluorescence was visualized on a Nikon Eclipse TE300 microscope to calculate viral titres according to Spearman-Kärber.
Subsequently, the inocula were adjusted using Schneiders media to yield a final titre of 5.75 log 10 TCID 50 /ml. 3, 5, 6, 7, 8, 9, 10, 12, 14, 16, 19 , and 20/21 dpi. Sheep body temperatures were recorded daily and clinical scoring was performed throughout as described previously (Darpel et al., 2007) .
| Vector competence
Culicoides sonorensis from a colony maintained at The Pirbright Institute (PIRB-s-3 strain) were fed on two sheep from each group at 6 dpi (UKG2007) or 7 dpi (FRA2017) to coincide with determined peak viraemia as described previously (Baylis, O'Connell, & Mellor, 2008) . Engorged individuals were incubated at 25°C for 8 days and surviving individuals were homogenized in GMEM using a tissue lyser (Qiagen) and made up to a final volume of 1 ml per sample (Veronesi et al., 2013) . Culicoides samples were analyzed in pools of eight individuals for BTV genome detection by using RT-qPCR as described below. Pools that reported a cycle threshold (C T value) less than that of the original blood meal in midges harvested on the day of feeding were considered to contain one or more individuals competent for BTV transmission. BTV RNA copies were determined by comparing sample C T values to the standard curves and expressed as log 10 genome copies/ml.
| Serological analyses
Whole blood samples were centrifuged at 3,000 g for 5 min and the serum was decanted and stored at +4°C until analysis. BTV antibodies were detected using the ID Screen ® Bluetongue Competition kit (ID Vet, Grabels, France) in accordance with the manufacturer's instructions. The serum neutralization test (SNT) against BTV-8 was performed as described previously (Batten et al., 2012) .
| Virus isolation
EDTA blood cells were washed 3× with PBS and sonicated as described in the World Organisation for Animal Health (OIE) manual (Savini, 2014) . KC cells were inoculated with 100 μl of washed blood and incubated at 26°C in Schneiders media (1% Amphotericin B, 1%
Penicillin/Streptomycin and 10% FBS). Media was replenished 24 hr post infection and cells were incubated for a further 6 days. Following the 7-day incubation, cells were harvested, centrifuged at 3,000 g for 5 min and the supernatant tested for BTV using RT-qPCR as described above. Virus was considered to have been isolated if the BTV C T value of the harvested material was 3-C T values less than that of the original EDTA-blood inoculum.
| Statistical analysis
Body temperatures and clinical scores were analyzed by comparing the maximum values and the dpi at which they occurred for each strain using the Wilcoxon rank-sum (also known as Mann-Whitney U) tests. The proportion of sheep showing moderate (as opposed to mild or no) clinical disease in each group was compared using a Fisher exact test. Viraemia for sheep infected with each strain was analyzed by comparing the maximum titer, the dpi at which it occurred and the area under the curve (a measure of total virus production; computed using the trapezium rule) using Wilcoxon ranksum tests. Non-parametric tests were preferred because of the small group sizes and potential non-normality of the data.
The vector competence for each BTV-8 strain was calculated from the number of positive pools and the number of pools tested using a binomial likelihood and noting that the probability of a positive pool is equal to 1 − (1 − b) n , where b is the vector competence (i.e., the probability of an individual midge becoming infected) and n is the number of midges in the pool. A second model was also considered in which vector competence was independent of strain, but depended on the viral titre (log 10 genome copies/ml) in the sheep on which each pool of midges fed, so that b = 1/(1 + exp (−a 0 − a 1 × titer)). Two sheep were euthanized on welfare grounds during the study, one in each group. The sheep from the UKG2007-inoculated group was euthanized at 9 dpi for reaching the humane endpoint (at the end of the moderate clinical spectrum) of the moderate study protocol. In this sheep, typical haemorrhagic lesions on mucosal membranes, coronary band, lymph nodes, pulmonary artery as well as the epithelium of the reticulum and omasum were observed during necropsy. The sheep from the FRA2017-inoculated group developed acute lameness on all four feet late in infection and was euthanized on humane grounds at 17 dpi.
The two transmission control sheep remained clinically unaffected other than exhibiting a mild nasal discharge over a 2-day period during the experiment. Figure 2 shows the BTV concentrations in EDTA blood over the study period. In five UKG2007-inoculated sheep and in three FRA2017-inoculated sheep BTV RNA was detected by using RT-qPCR at 2 dpi.
| Molecular analyses
BTV RNA was detected in all other inoculated sheep at 5 dpi with the exception of Sheep 17 (that had been inoculated with FRA2017).
Peak viraemia occurred earlier for UKG2007-inoculated sheep (between 5 and 6 dpi) than for FRA2017-inoculated sheep (5-9 dpi), but this difference was not statistically significant (p = 0.11). At peak viraemia, the BTV concentrations in blood (log 10 genome copies/ml)
were significantly (p = 0.021) higher for UKG2007-inoculated sheep 
| Vector competence
A total of 272 individual C. sonorensis fed on Sheep 6 and Sheep 9 that were infected with the UKG2007 strain survived incubation and this equated to 34 pools of midges for testing. A total of 280 individuals fed on Sheep 11 and Sheep 12 that were infected with FRA2017 were tested in 36 pools. Three midge pools from the UKG2007-inoculated sheep had lower C T values than the mean value obtained in C. sonorensis tested on the day of feeding (C T 30.9). C. sonorensis tested on the day of feeding on FRA2017-infected sheep had a mean C T value of 34.7. BTV RNA was not detected in any midge pools from the FRA2017-inoculated sheep.
Based on these results for pooled midges, the estimated vector competence (i.e., probability of an individual midge becoming infected) was 1.2% (95% CI: 0.3, 3.0) for UKG2007 and 0% (95% CI: 0, 0.7) for FRA2017, which are significantly different. Viral titres (log 10 genome copies/ml) in the sheep infected with UKG2007 were higher on the day of Culicoides feeding than for those infected with FRA2017 (8.3 and 8.0 compared with 7.3 and 6.6, respectively). An increase in competence was associated with an increase in titre, but this was not statistically significant (estimate for coefficient, a 1 : 2.6; 95% CI: −0.1, 3.6). Figure 3 shows the BTV antibody response using C-ELISA. In the sheep inoculated with UKG2007, five of the eight seroconverted by 7 dpi, and by 8 dpi all inoculated sheep had seroconverted (defined as <40% inhibition by the manufacturer). In the group inoculated with FRA2017, none of the sheep seroconverted at 7 dpi yet all had seroconverted by 9 dpi. Based on the ELISA results, SNTs were performed on serum samples obtained at 7, 9, 12, 14 and 21 dpi. Neutralizing antibodies were first detected at 7 and 9 dpi for UKG2007 and FRA2017-inoculated sheep, respectively. By 14 dpi, all sheep had neutralizing antibodies with titres (log 10 ) between 1.18 and 2.68, rising to between 1.60 and 2.81 at 21 dpi. The mean antibody titres at 21 dpi were 2.01 and 1.54 for the UKG2007 and FRA2017-inoculated sheep, respectively. The transmission control sheep in both groups did not seroconvert.
| Serological analyses
| Virus isolation
Virus isolation from EDTA blood was performed for all inoculated sheep at 2, 5, 7, 10, 12, 14, 16 and 21 dpi. For UKG2007-inoculated sheep, virus was isolated at 2 dpi (3/8 sheep), 5 dpi (7/8 sheep), 7-10 dpi (8/8 sheep) until 12 dpi (1 sheep). For FRA2017-inoculated sheep, virus was isolated at 5-7 dpi (6/8 sheep) until 10 dpi (4/8 sheep).
| DISCUSSION
Constant and largely unpredictable outbreaks of BTV present a significant global challenge in terms of proportionate response. This is exacerbated by our inability to accurately define the pathogenicity of emerging and re-emerging BTV strains, which is the main determining factor in vaccine production by industry and subsequent uptake by farmers. The aim of this study was to compare the infec- (Baylis et al., 2008; Flanagan, Wilson, Trueman, & Shepherd, 1982; Parsonson et al., 1987) . Other studies have further noted seroconversion of individual BTV-inoculated sheep or cattle either in the presence of very low detectable RNA levels by RT-qPCR (van der Sluijs et al., 2013) or in the absence of detectable viraemia, however, the latter was associated with either a low-titre (Baylis et al., 2008; Di Gialleonardo, Migliaccio, Teodori, & Savini, 2011) or a high-passage inoculum (Janowicz et al., 2015) .
Interestingly, a recent study also highlighted that a highly-passaged BTV-8 strain infected and was detectable in the skin and draining lymph nodes of inoculated sheep however did not result in detectable RNA levels in the systemic blood (Melzi et al., 2016) . Overall all these studies, including the data presented here, demonstrate that manifestation of clinical disease and viraemia varies in individual animals even when infected by the same route and with the same dosage of virus, highlighting differences in individual susceptibility to BTV infection. Alternatively, it is possible that this sheep had residual immunological memory from previous vaccination which could provide some protection from infection even in the absence of detectable antibodies. BTV antibodies can be detected in sheep up to 2.5 years following vaccination (Batten, Edwards, & Oura, 2013) and it has been estimated that they can persist for 5-6 years following infection or vaccination . The sheep used in our study were at an advanced age (>7 years old), as reported by the farmer and by assessing the general condition of the sheep.
Significantly greater RNA copy numbers were detected in sheep inoculated with the 2007 strain than the re-emerging strain. In addi- We have performed this experimental infection study in sheep; therefore, the impact of the re-emerged BTV-8 strain in cattle is yet to be determined experimentally. Previous experimental infection studies of other European BTV-8 strains in cattle did not result in overt disease or caused mild clinical signs which were in contrast with the clinical illness reported in sheep (Darpel et al., 2007; Di Gialleonardo et al., 2011; Martinelle et al., 2011 ). An experimental comparison of BTV-8 strain-specific virulence (similar to our study here) is likely to be more challenging in cattle.
Considering that morbidity rates in field conditions are likely to
be higher than what we have reported here and coupled with animal movement restrictions, it is probable that future incursions of the reemerged BTV-8 will have an economic impact on the livestock industry. Therefore, appropriate surveillance and vaccination strategies should be considered in advance of the likely incursion of this re-emerged BTV-8 strain.
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